Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.”

5 pharma patents match "BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.” · 30,257 patents in full index Clear search

  1. US 10064889

    Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  2. US 9446067

    Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  3. US 9220676

    Injectable in-situ crosslinked hydrogel and methods of making and using thereof

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  4. US 8647670

    Biocompatible rapid-gelating hydrogel and associated preparation method of spray

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  5. US 8158754

    Multiple modified derivatives of gelatin and crosslinked material thereof

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted